Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| WG Critical Care, LLC | 44567-247 | INTRAVENOUS | 10 g in 1 1 | 10/16/2023 | |
| B. Braun Medical Inc. | 0264-3123 | INTRAVENOUS | 1 g in 50 mL | 10/19/2022 | |
| Hikma Pharmaceuticals USA Inc. | 0143-9876 | INTRAVENOUS | 10 g in 1 1 | 1/8/2021 | |
| WG Critical Care, LLC | 44567-246 | INTRAVENOUS | 2 g in 1 1 | 10/12/2023 | |
| Sagent Pharmaceuticals | 25021-110 | INTRAVENOUS | 2 g in 1 1 | 1/3/2024 | |
| WG Critical Care, LLC | 44567-245 | INTRAVENOUS | 1 g in 1 1 | 10/18/2023 | |
| Fresenius Kabi USA, LLC | 63323-341 | INTRAVENOUS | 1 g in 1 1 | 10/6/2022 | |
| Fresenius Kabi USA, LLC | 63323-342 | INTRAVENOUS | 2 g in 1 1 | 6/10/2020 | |
| B. Braun Medical Inc. | 0264-3125 | INTRAVENOUS | 2 g in 50 mL | 10/19/2022 | |
| WG Critical Care, LLC | 44567-245 | INTRAVENOUS | 1 g in 1 1 | 10/12/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| CEFOXITIN JUNO cefoxitin (as sodium) 2 g powder for injection vial | 50311 | Medicine | A | 10/14/1994 | |
| CEFOXITIN JUNO cefoxitin (as sodium) 1 g powder for injection vial | 50310 | Medicine | A | 10/14/1994 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.